Vivian Prindle

Author Correction: Jawsamycin exhibits in vivo antifungal properties by inhibiting Spt14/Gpi3-mediated biosynthesis of glycosylphosphatidylinositol.

Nat Commun 2020 07 31;11(1):3913. Epub 2020 Jul 31.

Novartis Institutes for BioMedical Research, Novartis Pharma AG, Forum 1 Novartis Campus, CH-4056, Basel, Switzerland.

View Article and Find Full Text PDF

July 2020

Jawsamycin exhibits in vivo antifungal properties by inhibiting Spt14/Gpi3-mediated biosynthesis of glycosylphosphatidylinositol.

Nat Commun 2020 07 7;11(1):3387. Epub 2020 Jul 7.

Novartis Institutes for BioMedical Research, Novartis Pharma AG, Forum 1 Novartis Campus, CH-4056, Basel, Switzerland.

View Article and Find Full Text PDF

July 2020

Dark chemical matter as a promising starting point for drug lead discovery.

Authors:

Anne Mai Wassermann Eugen Lounkine Dominic Hoepfner Gaelle Le Goff Frederick J King Christian Studer John M Peltier Melissa L Grippo Vivian Prindle Jianshi Tao Ansgar Schuffenhauer Iain M Wallace Shanni Chen Philipp Krastel Amanda Cobos-Correa Christian N Parker John W Davies Meir Glick

Nat Chem Biol 2015 Dec 19;11(12):958-66. Epub 2015 Oct 19.

Novartis Institutes for BioMedical Research Inc., Cambridge, Massachusetts, USA.

View Article and Find Full Text PDF

December 2015

FR171456 is a specific inhibitor of mammalian NSDHL and yeast Erg26p.

Nat Commun 2015 Oct 12;6:8613. Epub 2015 Oct 12.

Novartis Institutes for BioMedical Research, Novartis Campus, Basel, CH-4056, Switzerland.

View Article and Find Full Text PDF

October 2015

Use of principal components analysis and protein microarray to explore the association of HIV-1-specific IgG responses with disease progression.

Authors:

Helen L Gerns Storey Barbra A Richardson Benson Singa Jackie Naulikha Vivian C Prindle Vladimir E Diaz-Ochoa Phil L Felgner David Camerini Helen Horton Grace John-Stewart Judd L Walson

AIDS Res Hum Retroviruses 2014 Jan 9;30(1):37-44. Epub 2013 Dec 9.

1 University of Washington , Seattle, Washington.

View Article and Find Full Text PDF

January 2014

Identification and evaluation of novel acetolactate synthase inhibitors as antifungal agents.

Authors:

Daryl L Richie Katherine V Thompson Christian Studer Vivian C Prindle Thomas Aust Ralph Riedl David Estoppey Jianshi Tao Jessica A Sexton Thomas Zabawa Joseph Drumm Simona Cotesta Jürg Eichenberger Sven Schuierer Nicole Hartmann N Rao Movva John A Tallarico Neil S Ryder Dominic Hoepfner

Antimicrob Agents Chemother 2013 May 11;57(5):2272-80. Epub 2013 Mar 11.

Novartis Institutes for BioMedical Research, Cambridge, Massachusetts, USA.

View Article and Find Full Text PDF

May 2013

Publications by authors named "Vivian Prindle"

Author Correction: Jawsamycin exhibits in vivo antifungal properties by inhibiting Spt14/Gpi3-mediated biosynthesis of glycosylphosphatidylinositol.

Authors:

Jawsamycin exhibits in vivo antifungal properties by inhibiting Spt14/Gpi3-mediated biosynthesis of glycosylphosphatidylinositol.

Authors:

Dark chemical matter as a promising starting point for drug lead discovery.

Authors:

FR171456 is a specific inhibitor of mammalian NSDHL and yeast Erg26p.

Authors:

Use of principal components analysis and protein microarray to explore the association of HIV-1-specific IgG responses with disease progression.

Authors:

Identification and evaluation of novel acetolactate synthase inhibitors as antifungal agents.

Authors: